(Q48328928)

10 February 2018

reason for preferred rank

title

Determination of propofol UDP-glucuronosyltransferase (UGT) activities in hepatic microsomes from different species by UFLC–ESI-MS (English)

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

10 July 2024

Determination of propofol UDP-glucuronosyltransferase (UGT) activities in hepatic microsomes from different species by UFLC-ESI-MS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20828969

10 July 2024

1 reference

Si-Cheng Liang

1

1 reference

10 February 2018

Guang-Bo Ge

2

1 reference

10 February 2018

Hui-Xin Liu

3

1 reference

10 February 2018

Hai-Tao Shang

4

1 reference

10 February 2018

Hong Wei

5

1 reference

10 February 2018

Zhong-Ze Fang

6

1 reference

10 February 2018

Liang-Liang Zhu

7

1 reference

10 February 2018

Yu-Xi Mao

8

1 reference

10 February 2018

Ling Yang

9

1 reference

10 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20828969

10 July 2024

publication date

13 August 2010

1 reference

10 February 2018

full work available at URL

number of pages

6

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0731708510004620?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

https://api.elsevier.com/content/article/PII:S0731708510004620?httpAccept=text/plain

10 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Journal of Pharmaceutical and Biomedical Analysis

10 July 2024

published in

1 reference

10 February 2018

volume

54

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

236-241

1 reference

10 February 2018

Prediction of drug metabolism and interactions on the basis of in vitro investigations.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Role of pharmacokinetics and metabolism in drug discovery and development

10 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years.

10 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system

10 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Drug glucuronidation by human renal UDP-glucuronosyltransferases.

10 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Direct high-performance liquid chromatography determination of propofol and its metabolite quinol with their glucuronide conjugates and preliminary pharmacokinetics in plasma and urine of man.

10 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

High-performance liquid chromatographic assay to detect hydroxylate and conjugate metabolites of propofol in human urine.

10 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

A universal radiochemical high-performance liquid chromatographic assay for the determination of UDP-glucuronosyltransferase activity

10 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Protein measurement with the Folin phenol reagent

10 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of daphnetin

10 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney

10 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis

10 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Glucuronidation of propofol and its analogs by human and rat liver microsomes

10 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Use of proton nmr spectroscopy to measure propofol metabolites in the urine of the female Caucasian patient.

10 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Urinary propofol metabolites in early life after single intravenous bolus

10 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model

10 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Death from propofol: accident, suicide, or murder?

10 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases

10 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JPBA.2010.07.049

10 July 2024

Identifiers

1 reference

10 February 2018

1 reference

10 February 2018